| |
|
References
1. Epstein J. and
Schubert, M. Oropharyngeal Mucositis is Cancer Therapy. Journal
of Oncology 2003; 17(12) 1767–1782
2. Innocenti M, Moscatelli, G, Lopez, S. Efficacy of Gelclair in
Reducing Pain in Patients with Oral Lesions: Preliminary
Findings From an Open Pilot Study. Journal of Pain and Symptom
Management 2002; 24(5): 456-457.
3. Pico, J-L., Avila-Garavito, A. and Naccache, P. Mucosititis :
Its Occurrence, Consequences and Treatment in the Oncology
Setting. The Oncologist 1998; 3: 446-451
4. Berndtson M. A Preliminary Study of Orassist (Gelclair) in
the management of Oral Mucositis. This paper was published in
Svensk Sjukhustandlakartidning (Swedish Hospital Dentistry) 2001
Nr 3 (Argang 26): 17-21.
5. De Cordi, D, Martina, S. Gelclair: potentially an efficacious
treatment for chemotherapy-induced mucositis. Presented at the
Italian Tumour League III congress for professional oncology
nurses, Conegliano, Italy, 10-12 October 2001.
6. Smith T, Gelclair: managing the symptoms of oral mucositis.
Hospital Medicine, 2001;62 (10): 623-626.
7. Rubenstein E et al. Clinical practice guidelines for the
prevention and treatment of cancer therapy-induced oral and
gastrointestinal mucositis. American cancer soc. 2004:
2026-2046.
8. Sonis S et al. Oral Mucositis and the clinical and economic
outcomes of hematopoietic stem –cell transplantation. J Clin
Oncol. 2001; 19: 2201-2205.
9. Elting L et al. The burdens of cancer therapy. Cancer 2003;
98: 1531-1539.
• Who can use Gelclair?
• What problems do oral lesions cause?
• How can Gelclair help?
• Further Information
• References
|
